XKRX:293780 (Korea (the Republic of))
Â
Ordinary Shares
â‚©
6520.00
(-3.12%)
Nov 29
Business Description
Aptabio Therapeutics Inc
ISIN : KR7293780003
Share Class Description:
XKRX:293780: Ordinary SharesCompare
Compare
Traded in other countries / regions
293780.Korea IPO Date
2019-06-12Description
Aptabio Therapeutics Inc is a South Korean pharmaceutical company involved in discovery and development of selective inhibitors of the NOX family of enzymes and aptamer-based anti-cancer drugs. The product portfolio of the company include Lipofector-Q, Plusfector, Lipofector-EXT, Lipofector-2000, Lipofector-EZ and Lipofector-pMAX.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 2.77 | |||||
| Equity-to-Asset | 0.59 | |||||
| Debt-to-Equity | 0.28 | |||||
| Debt-to-EBITDA | -0.93 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 0.53 | |||||
| Beneish M-Score | 50.92 | |||||
| WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -2.7 | |||||
| 3-Year EBITDA Growth Rate | -51.1 | |||||
| 3-Year EPS without NRI Growth Rate | -39.9 | |||||
| 3-Year FCF Growth Rate | -33.2 | |||||
| 3-Year Book Growth Rate | -5.6 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 47.04 | |||||
| 9-Day RSI | 42.17 | |||||
| 14-Day RSI | 39.94 | |||||
| 6-1 Month Momentum % | 36.26 | |||||
| 12-1 Month Momentum % | 4.1 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.5 | |||||
| Quick Ratio | 2.5 | |||||
| Cash Ratio | 2.19 | |||||
| Days Inventory | 4.3 | |||||
| Days Sales Outstanding | 117.48 | |||||
| Days Payable | 7.9 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -0.2 | |||||
| Shareholder Yield % | -6.83 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 8.22 | |||||
| Operating Margin % | -612.96 | |||||
| Net Margin % | -698.43 | |||||
| FCF Margin % | -547.8 | |||||
| ROE % | -35.93 | |||||
| ROA % | -22.28 | |||||
| ROIC % | -43.7 | |||||
| ROC (Joel Greenblatt) % | -224.85 | |||||
| ROCE % | -17.72 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 52.94 | |||||
| PB Ratio | 3.01 | |||||
| Price-to-Tangible-Book | 2.97 | |||||
| EV-to-EBIT | -7.94 | |||||
| EV-to-EBITDA | -8.22 | |||||
| EV-to-Revenue | 41.67 | |||||
| EV-to-FCF | -7.68 | |||||
| Price-to-Net-Current-Asset-Value | 15.98 | |||||
| Price-to-Net-Cash | 40.07 | |||||
| Earnings Yield (Greenblatt) % | -12.6 | |||||
| FCF Yield % | -10.95 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Aptabio Therapeutics Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚©) | 2,906.178 | ||
| EPS (TTM) (â‚©) | -870 | ||
| Beta | 2.05 | ||
| Volatility % | 97.4 | ||
| 14-Day RSI | 39.94 | ||
| 14-Day ATR (â‚©) | 417.375432 | ||
| 20-Day SMA (â‚©) | 6754 | ||
| 12-1 Month Momentum % | 4.1 | ||
| 52-Week Range (â‚©) | 4930 - 15490 | ||
| Shares Outstanding (Mil) | 22.3 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Aptabio Therapeutics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Aptabio Therapeutics Inc Stock Events
| Event | Date | Price(â‚©) | ||
|---|---|---|---|---|
| No Event Data | ||||
Aptabio Therapeutics Inc Frequently Asked Questions
What is Aptabio Therapeutics Inc(XKRX:293780)'s stock price today?
The current price of XKRX:293780 is â‚©6520.00. The 52 week high of XKRX:293780 is â‚©15490.00 and 52 week low is â‚©4930.00.
When is next earnings date of Aptabio Therapeutics Inc(XKRX:293780)?
The next earnings date of Aptabio Therapeutics Inc(XKRX:293780) is .
Does Aptabio Therapeutics Inc(XKRX:293780) pay dividends? If so, how much?
Aptabio Therapeutics Inc(XKRX:293780) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers